These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 4053493

  • 1. Evaluation of equilibrium gel filtration chromatography for the study of protein binding of aluminum in normal and uremic sera.
    Bertholf RL, Wills MR, Savory J.
    Clin Physiol Biochem; 1985; 3(5):271-6. PubMed ID: 4053493
    [Abstract] [Full Text] [Related]

  • 2. Serum binding of aluminum.
    King SW, Wills MR, Savory J.
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):161-9. PubMed ID: 515501
    [Abstract] [Full Text] [Related]

  • 3. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA, Evenson MA, Sarver KP, Wagnild JP.
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [Abstract] [Full Text] [Related]

  • 4. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L, Dall'taglio P, Buzio C.
    Clin Nephrol; 1975 Apr; 3(3):82-93. PubMed ID: 1139803
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J, Klahr S, Bricker NS.
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [Abstract] [Full Text] [Related]

  • 6. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B, Di Giulio S, Nicolaï A, Drüeke T, Debray M, Boulu RG.
    Nephrologie; 1982 Feb; 3(1):19-22. PubMed ID: 7088259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endogenous accumulation products and serum protein binding in uremia.
    McNamara PJ, Lalka D, Gibaldi M.
    J Lab Clin Med; 1981 Nov; 98(5):730-40. PubMed ID: 7299243
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of drug displacement of protein-bound bilirubin using gel filtration.
    Yeary RA, Wise KJ, Davis DR.
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):263-71. PubMed ID: 907411
    [Abstract] [Full Text] [Related]

  • 12. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
    Dasgupta A, Peng Y.
    Life Sci; 1991 Jun; 49(22):1603-9. PubMed ID: 1943464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Erythropoietic inhibitors in uremic serum.
    Freedman MH, Grunberger T, Saunders EF.
    Clin Invest Med; 1982 Jun; 5(4):237-40. PubMed ID: 7160111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of CZE for studying protein binding of aluminium in human serum.
    Blanco-González E, Soldado-Cabezuelo AB, Sanz-Medel A.
    Biomed Chromatogr; 1998 Jun; 12(3):143-4. PubMed ID: 9646916
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Equilibrium model for speciation of aluminum in serum.
    Harris WR.
    Clin Chem; 1992 Sep; 38(9):1809-18. PubMed ID: 1526019
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.